Hematology and Sickle Cell Program LeaderArnold Palmer Hospital for ChildrenOrlando, Florida, United States
PB0216 - Hemoglobin improvement among patients with hemophilia A treated with emicizumab prophylaxis: post hoc analysis of the HAVEN 1, 3, 4 and STASEY trials
Sunday, June 23, 202413:45 – 14:45 ICT